FDA Approval: Now What?
2:45 pm - Thursday 16th July 2026
- Defining strategies for EAP patients that are now ready to be transferred to commercial products
Speakers:
Director, Market Access Strategy & Marketing, National Accounts & Patient Services
Stealth BioTherapeutics